EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 203 / Numéro 1 (2009) J. Soc. Biol., 203 1 (2009) 99-106 Références
Accès gratuit
Numéro
J. Soc. Biol.
Volume 203, Numéro 1, 2009
Neurocytologie moléculaire et neuroendocrinologie
Page(s) 99 - 106
DOI https://doi.org/10.1051/jbio:2009002
Publié en ligne 10 avril 2009
  • Beltramo M., Stella N., Calignano T., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport revealed by selective inhibition. Science, 1997, 277, 1094–1097. [CrossRef] [PubMed] [Google Scholar]
  • Beltramo M., Bernardini N., Bertorelli R., Campanella M., Nicolussi E., Fredduzzi S., Reggiani. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur J Neurosci, 2006, 23, 1530–1538. [CrossRef] [PubMed] [Google Scholar]
  • Bernardini N., Foglia C., Tarozzo G., Zacchetti D., Grohovatz F., Beltramo M., Reggiani A. Modulation of primary sensory afferents activity by CB2 receptors agonists Program No. 722.2. Neuroscience Meeting. San Diego, CA: Society for Neuroscience, 2007. [Google Scholar]
  • Breivogel C.S., Sim L.J., Childers S.R. Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther, 1997, 282, 1632–1642. [PubMed] [Google Scholar]
  • Clayton N., Marshall F.H., Bountra C., O'Shaughnessy C.T. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain, 2002, 96, 253–260. [CrossRef] [PubMed] [Google Scholar]
  • Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., Lichtman A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signalling in mice lacking fatty acid amido hydrolase. Proc Natl Acad Sci USA, 2001, 98, 9371–9376. [Google Scholar]
  • Devane W.A., Dysarz F.A. 3rd, Johnson M.R., Melvin L.S., Howelett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol, 1988, 34, 605–613. [PubMed] [Google Scholar]
  • Devane W.A., Hanùs L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 1992, 258, 1882–1884. [Google Scholar]
  • Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A, 2002, 99, 10819–10824. [CrossRef] [PubMed] [Google Scholar]
  • Egertová M., Giang D.K., Cravatt B.F., Elphick M.R. A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc Biol Sci, 1998, 265, 2081–2085. [CrossRef] [PubMed] [Google Scholar]
  • Elmes S.J.R., Jhaveri M.D., Smart D., Kendall D.A., Chapman V. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain. Eur J Neurosci, 2004, 20, 2311–2320. [CrossRef] [PubMed] [Google Scholar]
  • Guindon J., Desroches J., Beaulieu P. The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors. Brit J Pharmacol, 2007, 150, 693–701. [CrossRef] [Google Scholar]
  • Hanuš L., Breuer A., Tchilibon S., Shiloah S., Goldenberg D., Horowitz M., Pertwee R.G., Ross R.A., Mechoulam R., Fride E. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci USA, 1999, 96, 14228–14233. [CrossRef] [Google Scholar]
  • Hohmann A.G., Herkenham M. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience, 1999, 90, 923–931. [CrossRef] [PubMed] [Google Scholar]
  • Hohmann A.G., Suplita R.L., Bolton N.M., Neely M.H., Fegley D., Mangieri R., Krey J.F., Walker J.M., Holmes P.V., Crystal J.D., Duranti A., Tontini A., Mor M., Tarzia G., Piomelli D. An endocannabinoid mechanism for stress-induced analgesia. Nature, 2005, 435, 7045, 1108–1112. [CrossRef] [PubMed] [Google Scholar]
  • Ibrahim M.M., Deng H., Zvonok A., Cockayne D.A., Kwan J., Mata H.P., Vanderah T.W., Lai J., Porreca F., Makriyannis A., Malan T.P. Jr. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA, 2003, 100, 10529–10533. [CrossRef] [Google Scholar]
  • Ibrahim M.M., Porreca F., Lai J., Albrecht P.J., Rice F.L., Khodorova A., Davar G., Makriyannis A., Vanderah T.W., Mata H.P., Malan T.P. Jr. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A, 2005, 102, 3093–3098. [CrossRef] [PubMed] [Google Scholar]
  • Iversen L.L. The science of marijuana. Oxford University Press 2000. [Google Scholar]
  • Jhaveri M.D., Richardson D., Chapman V. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Brit J Pharmacol, 2007, 152, 624–632. [CrossRef] [Google Scholar]
  • Lopez-Rodriguez M.L., Viso A., Ortega-Gutierres S., Lastres-Becker I., Gonzalez S., Fernandez-Ruiz J., Ramos J.A. Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid trasnporter inhibitors. J Med Chem, 2001, 46, 1512–1522. [CrossRef] [Google Scholar]
  • Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol, 2005, 5, 400–411. [CrossRef] [PubMed] [Google Scholar]
  • Malan T.P. Jr., Ibrahim M.M., Vanderah T.W., Makriyannis A., Porreca F. Inhibition of pain responses by activation of CB(2) cannabinoid receptors. Chem Phys Lipids, 2002, 121, 191–200. [CrossRef] [PubMed] [Google Scholar]
  • Malan T.P. Jr., Ibrahim M.M., Lai J., Vanderah T.W., Makriyannis A., Porreca F. CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? Curr. Opin. Pharmacol., 2003, 3, 62–67. [CrossRef] [PubMed] [Google Scholar]
  • Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990, 346, 561–564. [CrossRef] [PubMed] [Google Scholar]
  • Mechoulam R., Gaoni Y. The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Lett 1967, 1109–1111. [CrossRef] [Google Scholar]
  • Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993, 365, 61–65. [CrossRef] [PubMed] [Google Scholar]
  • Mitrirattanakul S., Ramakul N., Guerrero A.V., Matsuka Y., Ono T., Iwase H., Mackie K., Faull K.F., Spigelman I. Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain, 2006, 126, 102–114. [CrossRef] [PubMed] [Google Scholar]
  • Nackley A.G., Makriyannis A., Hohmann A.G. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience, 2003, 119, 747–757. [CrossRef] [PubMed] [Google Scholar]
  • Pertwee R.G. Cannabinoid receptor and pain. Progress in Neurobiology, 2001, 63, 569–611. [CrossRef] [PubMed] [Google Scholar]
  • Petrosino S., Palazzo E., de Novellis V., Bisogno T., Rossi F., Maione S, Di Marzo V. Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology, 2007, 52, 415–422. [CrossRef] [PubMed] [Google Scholar]
  • Petitet F., Donlan M., Michel A. GPR55 as a new cannabinoid receptor: still a long way to prove it. Chem Biol Drug Des, 2006, 67, 252–253. [CrossRef] [PubMed] [Google Scholar]
  • Piomelli D. The molecular logic of endocannabinoid signaling. Nat Rev Neurosci, 2003, 4, 873–884. [CrossRef] [PubMed] [Google Scholar]
  • Quartilho A., Mata H.P., Ibrahim M.M., Vanderah T.W., Porreca F., Makriyannis A., Malan T.P. Jr. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology, 2003, 99, 955–960. [CrossRef] [PubMed] [Google Scholar]
  • Ryberg E., Larsson N., Sjögren S., Hjorth S., Hermansson N.O., Leonova J., Elebring T., Nilsson K., Drmota T., Greasley P.J. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol, 2007, 152, 1092–1101. [CrossRef] [PubMed] [Google Scholar]
  • Sagar D.R., Millns P.J., O'Shaughnessey C.T., Kendall D.A., Chapman V. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur J Neurosci, 2005, 22, 371–379. [CrossRef] [PubMed] [Google Scholar]
  • Salio C., Fischer J., Franzoni M.F., Conrath M. Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. Neuroscience, 2002, 110, 755–764. [CrossRef] [PubMed] [Google Scholar]
  • Valenzano K.J., Tafesse L., Lee G., Harrison J.E., Boulet J.M., Gottshall S.L., Mark L., Pearson M.S., Miller W., Shan S., Rabadi L., Rotshteyn Y., Chaffer S.M., Turchin P.I., Elsemore D.A., Toth M., Koetzner L., Whiteside G.T. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW 405833, utilizing rodent models of acute and chronic pain, anxiety and catalepsy. Neuropharmacology, 2005, 48, 658–672. [CrossRef] [PubMed] [Google Scholar]
  • Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman Q.J., Patel K.D., Sharkey K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 2005, 310, 329–332. [CrossRef] [PubMed] [Google Scholar]
  • Walker J.M., Huang S.M., Strangman N.M., Tsou K., Sañudo-Peña M.C. Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci USA, 1999, 96, 12198–12203. [CrossRef] [Google Scholar]
  • Walker J.M., Hohmann A.G. Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol, 2005, 168, 509–554. [CrossRef] [PubMed] [Google Scholar]
  • Wotherspoon G., Fox A., McIntyre P., Colley S., Bevan S., Winter J. Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience, 2005, 135, 235–245. [CrossRef] [PubMed] [Google Scholar]
  • Zhang J., Hoffert C., Vu. H.K., Groblewski T., Ahmad S., O'Donnell D. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci, 2003, 17, 2750–2754. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.